The "ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling (ALLMARK)" Study.
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2015
At a glance
- Drugs Aliskiren (Primary) ; Losartan
- Indications Hypertension; Left ventricular hypertrophy
- Focus Biomarker; Therapeutic Use
- Acronyms ALLMARK
- Sponsors Novartis; Novartis Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 27 Jan 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 25 Feb 2013 Planned end date changed from 1 Jun 2013 to 1 May 2013 as reported by ClinicalTrials.gov.